Canada markets closed

Yunkang Group Limited (2325.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
10.680+0.380 (+3.69%)
At close: 02:58PM HKT
Full screen
Previous Close10.300
Open10.800
Bid10.600 x N/A
Ask10.700 x N/A
Day's Range10.600 - 10.800
52 Week Range10.040 - 14.080
Volume10,000
Avg. Volume83,262
Market Cap6.474B
Beta (5Y Monthly)-0.38
PE Ratio (TTM)N/A
EPS (TTM)-0.180
Earnings DateN/A
Forward Dividend & Yield0.02 (0.19%)
Ex-Dividend DateJul 04, 2024
1y Target Est13.99
  • PR Newswire

    Yunkang Group participated in S&P Global CSA for the first time Ranks above 89% of participating global peers

    Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its score in the "S&P Global Corporate Sustainability Assessment" ("S&P Global CSA").

  • PR Newswire

    Yunkang Announces 2023 Annual Results, Revenue Reaches RMB892 Million

    Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its annual results for the year ended December 31, 2023 (the "Reporting Period"). In 2023, the Group continued to expand its business network and services across the country, the Group's revenue reached RMB891.5 million. The Group's routine testing business achieved a healthy and steady year-on-year growth of 26.9% during the Reporting Period. Due to enhanced